Cellectis (CLLS) Cash from Financing Activities (2015 - 2026)

Cellectis (CLLS) recorded quarterly Cash from Financing Activities of -$4.9 million in Q1 2026, down 18.36% quarter-over-quarter from -$4.1 million in Q4 2025, and down 19.8% on a YoY basis from -$6.1 million in Q1 2025.

Cellectis (CLLS) Cash from Financing Activities (2015 - 2026) Analysis & Trends

Cellectis' Cash from Financing Activities history runs 12 years deep, the most recent figure standing at -$4.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 19.8% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$17.6 million (down 124.03% YoY), while the FY2025 annual figure was -$16.8 million, down 118.81% from the prior year.
  • Cash from Financing Activities was -$4.9 million for Q1 2026 at Cellectis, down from -$4.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $78.5 million in Q2 2024 to a low of -$13.7 million in Q4 2022.
  • Historically, Cash from Financing Activities has averaged $8.4 million across 5 years, with a median of $1.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities tumbled 862.19% in 2022, then jumped 653.5% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$13.7 million in 2022, then soared by 403.68% to $41.6 million in 2023, then sank by 92.97% to $2.9 million in 2024, then tumbled by 241.54% to -$4.1 million in 2025, then slipped by 18.36% to -$4.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$4.9 million (Q1 2026), -$4.1 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Cellectis 17.40 Bn 17.21 Bn - -4.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.90 Mn
Mar 31, 2026 -4.90 Mn
Dec 31, 2025 -4.14 Mn
Dec 31, 2025 -4.14 Mn
Sep 30, 2025 -4.26 Mn
Sep 30, 2025 -4.26 Mn
Jun 30, 2025 -4.27 Mn
Jun 30, 2025 -4.27 Mn
Mar 31, 2025 -4.09 Mn
Mar 31, 2025 -4.09 Mn
Dec 31, 2024 2.93 Mn
Dec 31, 2024 2.93 Mn
Sep 30, 2024 -4.22 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 78.51 Mn
Jun 30, 2024 78.51 Mn
Mar 31, 2024 11.90 Mn
Mar 31, 2024 11.90 Mn
Dec 31, 2023 41.58 Mn
Dec 31, 2023 41.58 Mn